A blood-based composite panel that screens Alzheimer’s disease

BACKGROUND: Blood tests would be much easier to implement in the clinical diagnosis of Alzheimer’s disease (AD) as minimally invasive measurements. Multiple inspection technologies promoted AD-associated blood biomarkers’ exploration. However, there was a lack of further screening and validation for...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Li, Ying, Li, Yan, Li, Tingting, Wang, Qi, Wang, Qigeng, Cao, Shuman, Li, Fangyu, Jia, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189970/
https://www.ncbi.nlm.nih.gov/pubmed/37194047
http://dx.doi.org/10.1186/s40364-023-00485-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189970/
https://www.ncbi.nlm.nih.gov/pubmed/37194047
http://dx.doi.org/10.1186/s40364-023-00485-6

Ejemplares similares